HCAT vs NRC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
HCAT
NRC
Investment Advisor Scores
NRC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HCAT | NRC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 7.764 | 17.2117 | HCAT |
| PEG Ratio | 0 | 1.3234 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -12.7% | 4.0% | NRC |
| Earnings Growth | 0.0% | -44.0% | HCAT |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.7/100 | 38.6/100 | HCAT |
| Profit Margin | -90.6% | 4.2% | NRC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | SELL | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HCAT
NeutralMixed signals - no dominant trend phase, RSI 32
NRC
MarkupPrice above SMA50, rising 50-day trend (2.7% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | HCAT | NRC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 38.4 | 21.1 |
| Trailing P/E | — | 90.9 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.0% |
| Gross Margin | 0.5% | 0.6% |
| Operating Margin | -0.1% | 0.0% |
| EPS | -3.54 | 0.24 |
| Dividend Yield | — | 0.03% |